Regular ArticleEffects of formoterol (Oxis® Turbuhaler®) and ipratropium on exercise capacity in patients with COPD
Under an Elsevier user license
open archive
Keywords
formoterol
COPD
exercise capacity.
Cited by (0)
- f1
Correspondence should be addressed to: H.A.M. Kerstjens, MD, PhD, Department of Pulmonary Diseases, University Hospital Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Fax:+31 50 3 61 93 20; E-mail: [email protected]
Copyright © 2002 Elsevier Science Ltd. All rights reserved.